Avid Bioservices, Inc. reported earnings results for the third quarter and nine months ended January 31, 2024. For the third quarter, the company reported sales was USD 33.82 million compared to USD 38.02 million a year ago. Net loss was USD 6.01 million compared to USD 0.247 million a year ago. Basic loss per share from continuing operations was USD 0.09. Diluted loss per share from continuing operations was USD 0.09.
For the nine months, sales was USD 96.94 million compared to USD 109.47 million a year ago. Net loss was USD 17.65 million compared to net income of USD 0.594 million a year ago. Basic loss per share from continuing operations was USD 0.28 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.28 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.